News

Key Points Healthcare is a complex sector, but some dividend payers have proven incredibly reliable over the long ...
Trump has rolled back many of his steepest tariffs over recent months, including a sky-high levy on China, the top source of ...
In addition to these quarterly earnings, Merck & Co., Inc. (NYSE:MRK) has shown its resilience as a dividend stock. The ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Germany’s Merck KGaA is paying $45 million upfront for rights to a potentially first-in-class drug for colorectal cancer (CRC) being developed by New York biotech Inspirna. The agreement gives ...